Tablets & capsules
Immediate-release, sustained-release, and enteric-coated solid oral dosage forms manufactured across multiple high-throughput facilities.
Global pharmaceutical manufacturing & research
Apex Evergreen Pharmaceuticals — 21 manufacturing facilities, every major regulatory accreditation, medicines trusted across 80+ markets.
Proven scale
Trusted across 80+ markets
What we make
From sterile injectables to complex oncology therapies — manufactured across 21 facilities, each engineered for its specialty.
Immediate-release, sustained-release, and enteric-coated solid oral dosage forms manufactured across multiple high-throughput facilities.
Hormonal injectables, veterinary biologicals, and sterile preparations manufactured in dedicated aseptic suites with full cold-chain capability.
WHO-certified biological products for human and veterinary use, including PCV-13 and hormonal injectables.
Premium eye drops and ophthalmic solutions manufactured to the highest sterility and efficacy standards.
Advanced intranasal drug-delivery systems with precision metered-dose technology for systemic and local therapeutic applications.
Syrups, suspensions, and solutions formulated for precise bioavailability, paediatric use, and tropical-climate stability.
Creams, ointments, gels, and lotions developed for dermatological, anti-fungal, and musculoskeletal applications worldwide.
Effervescent granules, nutrition supplements, and therapeutic sachets bridging pharmaceutical quality with wellness.
Dedicated oncology manufacturing under stringent containment, delivering complex therapies to global markets.
Purpose-built hormonal manufacturing in segregated facilities, ensuring cross-contamination control and product integrity.
Dedicated beta-lactam facilities engineered to the strictest segregation and safety standards.
Active pharmaceutical ingredients and intermediates supporting vertical integration across our formulation portfolio.
Compliance & accreditation
Every product manufactured by Apex Evergreen meets — and typically exceeds — the requirements of the world's most demanding regulatory authorities.
World Health Organization GMP
The global baseline for pharmaceutical manufacturing quality. All 21 facilities operate under WHO Good Manufacturing Practice guidelines, ensuring product safety, efficacy, and consistency.
US Food & Drug Administration
Multiple facilities hold active USFDA approvals, enabling compliant supply to the United States — one of the world's most stringent pharmaceutical regulatory jurisdictions.
European GMP Certification
EU-GMP certified facilities provide the gateway to European markets, meeting the rigorous EMA quality requirements for pharmaceutical import across EU member states.
Pharmaceutical Inspection Co-operation Scheme
Held by several of our facilities — one of the most comprehensive pharmaceutical inspection frameworks globally, validating our quality systems against international standards.
We are only the second company in the world — after Pfizer — to achieve access to the PCV-13 vaccine at scale. Protecting against 13 serotypes of Streptococcus pneumoniae, PCV-13 guards against pneumonia, meningitis, and septicaemia — diseases that claim over 1.6 million lives annually. For markets across Latin America, Sub-Saharan Africa, and Southeast Asia, our access to WHO-certified PCV-13 is not a business achievement.
It is a lifesaving imperative.
Global presence
From Latin America to Sub-Saharan Africa, the Gulf to Southeast Asia — Apex Evergreen medicines reach patients across six continents, backed by the regulatory approvals each market demands.
Africa
Approved across 40+ African markets
Middle East
UAE, Saudi Arabia, Iraq
CIS Region
Across the Commonwealth of Independent States
Latin America
Chile, Brazil, Mexico, Peru
Southeast Asia
Malaysia, Singapore, Indonesia
Europe
France, Romania, Moldova, Greece
Partner with Apex Evergreen
Whether you're sourcing a trusted manufacturing partner, licensing a product, or advancing a molecule through clinical trials — Apex Evergreen is ready.
Access our full portfolio across 80+ markets.
Become a partnerExplore in-licensing and out-licensing opportunities.
Discuss licensingAdvance your molecule from discovery through clinical trials.
Explore our CRO